I'm new to this group. Am a two year 4 month lung cancer survivor in remission from a small slow-growing BAC (now called NSCLC). At 9 mm x 7 mm tumor removed from lower left lobe by composite basilar segmentectomy. Genomic testing showed KRAS mutation, p.G12A. Even at stage 1aTN0, 40-45% chance of reocurrence within 5 yrs. KRAS never has been cracked & still basically untreatable. What can you comment on current research?